Clinical Trials Logo

Epilepsy clinical trials

View clinical trials related to Epilepsy.

Filter by:

NCT ID: NCT00210652 Completed - Epilepsy Clinical Trials

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Start date: July 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who are currently being treated with 1 or 2 concomitant antiepileptic drugs.

NCT ID: NCT00210574 Completed - Epilepsy, Absence Clinical Trials

A Pilot Study of Topiramate in Childhood Absence Epilepsy

Start date: March 2005
Phase: Phase 2
Study type: Interventional

Limited data exist on the effectiveness of antiepileptic drugs for treatment of childhood absence epilepsy. Preliminary data suggest that topiramate may be an effective drug for this condition. The present study is designed to provide further evidence of the potential effectiveness of topiramate for childhood absence epilepsy, as well as preliminary information about a potential target dose for future study.

NCT ID: NCT00210522 Completed - Epilepsy Clinical Trials

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Start date: May 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of the novel compound RWJ-333369 in reducing the frequency of seizures in patients with epilepsy.

NCT ID: NCT00207935 Completed - Epilepsy Clinical Trials

Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population

Start date: August 2005
Phase: Phase 4
Study type: Interventional

This study is being done to see if children with learning problems can learn how to swallow pills without chewing them. The reason this is important is that if a person has seizures, medications must be taken every day. Most medications need to be taken 2 or 3 times per day. Some medications have slow release and only are taaken once per day. Medications with slow release usually come in capsule form and cannot be opened or chewed. This study investiates whether children with developmental delay can be taught how to swalow pills.

NCT ID: NCT00204815 Completed - Epilepsy Clinical Trials

Bone Mineral Density in Pediatric Epilepsy

Start date: January 2005
Phase: N/A
Study type: Observational

What are the effects of the currently used AEDs on bone mineralization in children and adolescents between the ages of 8 to 18? This is a pilot observational study using DEXA scans to measure bone mineral density in 100 patients The primary objective is to collect preliminary data on bone mineral density, body weight, dietary calcium intake, and activity level.

NCT ID: NCT00204360 Completed - Epilepsy Clinical Trials

Pediatric Epilepsy Database

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this database is to collect information for clinical purposes on all children being treated for seizure disorders.

NCT ID: NCT00203333 Completed - Arrhythmia Clinical Trials

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death

Start date: April 2002
Phase: Phase 2/Phase 3
Study type: Observational

People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.

NCT ID: NCT00195052 Recruiting - Epilepsy Clinical Trials

Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients

Start date: May 2002
Phase:
Study type: Observational

The purpose of this study is to develop a technique for the intraoperative identification of human functional and epileptiform cortex using intrinsic signal imaging. The investigators propose that the ability to optically monitor neuronal activity in a large area of cortex in "real-time" will be a more sensitive and time-saving method than the electrical methods currently available. The applications of this technique will not only theoretically increase the safety and efficacy of many of neurosurgical procedures, but will be useful as an investigational tool to study human cortical physiology.

NCT ID: NCT00194870 Completed - Epilepsy Clinical Trials

Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy

Start date: October 2003
Phase: N/A
Study type: Interventional

Patients with epilepsy undergoing deep brain stimulation (DBS) have electroencephalograms (EEGs) recorded before and during their stimulation treatment. Subsequently the investigators will be using computer-assisted analysis of the digitally-recorded EEG signals to assess the effects of DBS on the brain-wave frequency content and any abnormal seizure-like patterns that may be present.

NCT ID: NCT00188500 Recruiting - Epilepsy Clinical Trials

Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy

Start date: August 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether patients with uncontrolled epilepsy can follow a low carbohydrate diet long-term and if so, how will that diet affect their seizures